FDA updates labeling for RIFADIN FDA Approval Dec. 31, 2025, 13:45 UTC Labeling changes approved for SANOFI AVENTIS US. Active ingredient: RIFAMPIN. Decision date: 12/05/2025 Full text
There are no comments here yet...